Polyphor AG operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Polyphor AG with three other
pharmaceutical manufacturers in Europe:
sales of 6.70 million Swiss Francs [US$6.76 million]
of which 100%
was Pharmaceuticals Manufacture),
Biotec Pharmacon ASA
(66.77 million Norwegian Kroner [US$7.44 million]
of which 51%
was Enzymes), and
based in France
(6.13 million Euro [US$6.79 million]
of which 91%
was Operating segment -Rest of the world).